All News

2022

June

Media Release / Jun 17, 2022

Sandoz Application for proposed biosimilar adalimumab’s high concentration formulation accepted by EMA

Read More
Media Release / Jun 10, 2022

HEXAL launches Dimethyl fumarate HEXAL® a generic drug for Tecfidera®, in Germany, offering an economically efficient treatment option for the care of adult patients with multiple sclerosis*

Read More
Living with MS
Featured News / Jun 07, 2022

Living with Multiple Sclerosis (MS) – A disease with 1000 faces

Read More

May

Media Release / May 31, 2022

Sandoz announces new global ‘Act4Biosimilars’ initiative, to improve patient access and increase adoption by at least 30% in 30+ countries by 2030

Read More
Media Release / May 27, 2022

Sandoz appoints new Board representative to global AMR Industry Alliance

Read More
Media Release / May 12, 2022

Sandoz launches first generic pirfenidone in US for patients with idiopathic pulmonary fibrosis, growing its respiratory portfolio

Read More

April

Media Release / Apr 26, 2022

Novartis delivers solid sales and profit growth. Strong performance of in-market brands supports confidence in mid-term growth outlook

Read More
Media Release / Apr 14, 2022

Sandoz launches generic brimonidine tartrate/timolol maleate eyedrop in US for patients with ocular hypertension, expanding leading ophthalmic portfolio

Read More
Media Release / Apr 06, 2022

Sandoz extends collaboration agreement to drive cutting-edge digital solutions in global fight against antimicrobial resistance (AMR)

Read More

March

Media Release / Mar 14, 2022

Sandoz targets growth opportunities in respiratory and complex generics through acquisition of respiratory device company Coalesce

Read More